# Follow-Up of Hearing Impairment in Patients with Congenital CMV Infection

**Authors:** Ron Fisher, Miriam Geal Dor, Cahtia Adelman, Michal Kaufmann-Yehezkely, Sagit Stern Shavit

PMC · DOI: 10.3390/children13020230 · Children · 2026-02-06

## TL;DR

Children with congenital CMV can develop hearing loss later in life, often after initially normal hearing, requiring long-term monitoring for accurate diagnosis and management.

## Contribution

The study reveals distinct hearing trajectory patterns in congenital CMV-related SNHL, emphasizing the need for prolonged follow-up and risk-stratified surveillance.

## Key findings

- Delayed-onset SNHL in cCMV occurs after a period of normal hearing and can appear at various ages.
- Better-ear hearing is more preserved in delayed-onset SNHL compared to congenital SNHL.
- Longer follow-up is needed for children with SNHL, as hearing loss can progress dynamically and asymmetrically.

## Abstract

What are the main findings?
•Delayed-onset SNHL in children with congenital CMV frequently develops after an initial period of normal hearing and may present over a broad age range.•While poorer-ear thresholds are comparable, better-ear hearing remains more preserved in delayed-onset SNHL compared with congenital SNHL.

Delayed-onset SNHL in children with congenital CMV frequently develops after an initial period of normal hearing and may present over a broad age range.

While poorer-ear thresholds are comparable, better-ear hearing remains more preserved in delayed-onset SNHL compared with congenital SNHL.

What are the implications of the main findings?
•cCMV-related hearing loss follows heterogeneous and asymmetric trajectories, with dynamic changes and progression in a substantial proportion of children.•Detection and characterization of SNHL in cCMV depend on prolonged follow-up, underscoring both its clinical value and practical challenges.

cCMV-related hearing loss follows heterogeneous and asymmetric trajectories, with dynamic changes and progression in a substantial proportion of children.

Detection and characterization of SNHL in cCMV depend on prolonged follow-up, underscoring both its clinical value and practical challenges.

Background/Objectives: Congenital cytomegalovirus (cCMV) is a leading non-genetic cause of childhood sensorineural hearing loss (SNHL), characterized by heterogeneous and dynamic hearing outcomes. Hearing impairment may be present at birth or emerge later in childhood. This study aimed to characterize hearing trajectories and laterality patterns in children with cCMV, with emphasis on congenital versus delayed-onset SNHL. Methods: We conducted a retrospective study of children with confirmed cCMV who underwent longitudinal audiologic follow-up. Hearing loss was classified as congenital SNHL or delayed-onset SNHL. Better- and poorer-ear thresholds, bilateral involvement, longitudinal changes, and follow-up duration were analyzed. Results: Of 195 included children, 59 (30%) developed SNHL. Congenital SNHL was present in 34 children (17%), while delayed-onset SNHL developed in 25 of 161 children (16%) who were born with normal hearing. Of these delayed-onset cases, 20 (80%) were asymptomatic at birth, while 5 (20%) presented with non-audiological neonatal symptoms. Longitudinal observation of the delayed-onset subgroup revealed that 36 ears developed SNHL during follow-up, spanning infancy through later childhood, including one case identified in early adulthood. Better-ear thresholds were significantly better preserved in delayed-onset SNHL, while poorer-ear thresholds were comparable across groups. Children with SNHL had substantially longer follow-up duration (60 ± 44.5 months) compared with those with normal hearing (37 ± 24.4 months). Conclusions: Children with cCMV-related SNHL exhibit dynamic and asymmetric hearing trajectories with clinically relevant differences between congenital and delayed-onset SNHL. These findings underscore the necessity of a risk-stratified, long-term surveillance framework that ensures individualized long-term monitoring and promotes sustained adherence to follow-up.

## Linked entities

- **Diseases:** sensorineural hearing loss (MONDO:0010576), SNHL (MONDO:0020678)

## Full-text entities

- **Diseases:** symmetric (MESH:D008069), meningitis (MESH:D008580), CHL (MESH:D006314), congenital hearing loss (MESH:D003638), auditory damage (MESH:D001304), hepatosplenomegaly (MESH:C535727), cochlear or neural degeneration (MESH:D015834), intracranial calcifications (MESH:C537905), hereditary immune disorder (MESH:D009386), injury (MESH:D014947), inflammatory (MESH:D007249), intrauterine growth restriction (MESH:D005317), middle-ear disease (MESH:D010033), Neurologic abnormalities (MESH:D009461), Hearing Impairment (MESH:D034381), Congenital SNHL (MESH:D006319), Jaundice (MESH:D007565), microcephaly (MESH:D008831), white matter abnormalities (MESH:D056784), language, motor, or vestibular deficits (MESH:D007806), vestibular dysfunction (MESH:D015837), Congenital CMV Infection (MESH:D003586), auditory impairment (MESH:D006311), craniofacial anomalies (MESH:D019465), congenital infection (MESH:D007239), vestibulopathy (MESH:D065635), thrombocytopenia (MESH:D013921), intracranial abnormalities (MESH:D001927), viral injury (MESH:D014777), neuroimaging abnormalities (MESH:D000014), infectious disease (MESH:D003141), subependymal cysts (MESH:D003560), ventriculomegaly (MESH:D006849), developmental delay (MESH:D002658), hepatitis (MESH:D056486), neural degeneration (MESH:D009410)
- **Chemicals:** valganciclovir (MESH:D000077562)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939066/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939066/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939066/full.md

---
Source: https://tomesphere.com/paper/PMC12939066